PAS
RLYB icon

Point72 Asia (Singapore)’s Rallybio RLYB Stock Holding History

Point72 Asia (Singapore)’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,251
Closed -$6.55K – 1208
2025
Q1 		$6.55K Sell
1,251
-1,581
-56% -$9.99K ﹤0.01% 766
2024
Q4 		$21.7K Buy
2,832
+67
+2% +$561 0.01% 651
2024
Q3 		$25.9K Sell
2,765
-2,926
-51% -$28.2K ﹤0.01% 787
2024
Q2 		$61K Buy
+5,691
New +$77.1K 0.01% 604

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

Point72 Asia (Singapore)'s RLYB Position: Q2 2025 in Review

Point72 Asia (Singapore) sold out of Rallybio (RLYB) in Q2 2025, closing a stake of 1,251 shares — an estimated $6.55K sold.

Point72 Asia (Singapore) first reported a position in RLYB in Q2 2024 and held it in 4 quarters. The position peaked at $61K in Q2 2024. 48 funds tracked by Wall St. Rank hold RLYB as of Q2 2025.

  • Point72 Asia (Singapore) reported no remaining Rallybio position as of Q2 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 1,251 Rallybio shares in Q2 2025, an estimated $6.55K.
  • Point72 Asia (Singapore) first reported a position in Rallybio in Q2 2024 and held it in 4 quarters.
  • Point72 Asia (Singapore)'s Rallybio position peaked at $61K in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Rallybio as of Q2 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2025, filed 14 Aug 2025.